Chemoinformaics analysis of 3-Hydroxy-7,8-didehydro-beta-ionone
| Molecular Weight | 206.285 | nRot | 0 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 8 |
| Exact Molecular Weight | 206.131 | nRing | 1 |
| Solubility: LogS | -2.5 | nHRing | 0 |
| Solubility: LogP | 2.69 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 35.3163 |
| nHD | 1 | BPOL | 18.9257 |
| QED | 0.486 |
| Synth | 3.769 |
| Natural Product Likeliness | 2.305 |
| NR-PPAR-gamma | 0.185 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.035 |
| Pgp-sub | 0.086 |
| HIA | 0.014 |
| CACO-2 | -4.504 |
| MDCK | 0.0000265 |
| BBB | 0.254 |
| PPB | 0.841749 |
| VDSS | 1.839 |
| FU | 0.0679601 |
| CYP1A2-inh | 0.136 |
| CYP1A2-sub | 0.579 |
| CYP2c19-inh | 0.821 |
| CYP2c19-sub | 0.865 |
| CYP2c9-inh | 0.569 |
| CYP2c9-sub | 0.744 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.65 |
| CYP3a4-inh | 0.059 |
| CYP3a4-sub | 0.468 |
| CL | 8.189 |
| T12 | 0.441 |
| hERG | 0.002 |
| Ames | 0.396 |
| ROA | 0.515 |
| SkinSen | 0.852 |
| Carcinogencity | 0.84 |
| EI | 0.841 |
| Respiratory | 0.986 |
| NR-Aromatase | 0.284 |
| Antiviral | Yes |
| Prediction | 0.630459 |